Ursoliv is a new generation hepatoprotector. Ursoliv is a combination of ursodeoxycholic acid and the prebiotic compound, lactulose.

Ursoliv combines the hepatoprotective, cholagogic, cholelitholitic, lipid-lowering effect and hypocholesteremic effect of ursodeoxycholic acid and the prebiotic effect of lactulose, promoting intestinal microbial balance and GI barrier function. An impaired GI barrier allows the access of pathogenic bacteria or their metabolites to the liver through the portal vein, and the liver-gut axis. This is the cause of several liver diseases.

Ursoliv is indicated for:

Primary biliary cirrhosis with absence of decompensation symptoms.


Bile-reflux gastritis.